CTSO
CTSO
NASDAQ · Health Care

Cytosorbents Corp

$4.02
-0.36 (-8.22%)
Financial Highlights (FY 2026)
Revenue
1.92M
Net Income
-423,469
Gross Margin
71.5%
Profit Margin
-22.1%
Rev Growth
+2.2%
D/E Ratio
2.82
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 71.5% 71.5% 39.9% 39.9%
Operating Margin -41.3% -37.2% 7.7% 9.4%
Profit Margin -22.1% -21.0% 5.8% 6.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.92M 1.87M 13.44M 11.40M
Gross Profit 1.37M 1.34M 5.36M 4.54M
Operating Income -790,935 -696,313 1.03M 1.07M
Net Income -423,469 -372,808 783.9K 740.1K
Gross Margin 71.5% 71.5% 39.9% 39.9%
Operating Margin -41.3% -37.2% 7.7% 9.4%
Profit Margin -22.1% -21.0% 5.8% 6.5%
Rev Growth +2.2% +2.2% -9.4% -6.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 5.24M 5.24M 11.74M 10.77M
Total Equity 1.85M 1.85M 22.15M 20.33M
D/E Ratio 2.82 2.82 0.53 0.53
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -727,325 -675,886 1.54M 1.35M
Free Cash Flow — — 1.21M 903.7K